---
created: '2026-02-13T18:17:33.084956Z'
description: Serum or plasma neurofilament light chain measurement using ultrasensitive
  immunoassays. A universal blood biomarker for neurodegeneration with applications
  across multiple neurological diseases.
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/biomarker/blood-nfl/
slug: blood-nfl
tags:
- biomarker
- blood-test
- neurodegeneration
- universal
- prognosis
templateEngineOverride: njk
title: Blood NfL
type: biomarker
updated: '2026-02-13T18:17:33.084956Z'
---

{% raw %}
<h1>Blood NfL (Serum/Plasma Neurofilament Light Chain)</h1>
<h2>Overview</h2>
<p>Blood-based neurofilament light chain (NfL) measurement has been enabled by ultrasensitive immunoassay technology (SIMOA). Serum or plasma NfL correlates highly with CSF NfL (r~0.85-0.90) and provides a minimally invasive marker of ongoing neurodegeneration across multiple diseases. In 2024, the first FDA-cleared blood NfL test became available.</p>
<h2>Platform and Technology</h2>
<h3>Ultrasensitive Immunoassays</h3>
<table>
<thead>
<tr>
<th>Platform</th>
<th>Manufacturer</th>
<th>Sensitivity</th>
<th>Notes</th>
</tr>
</thead>
<tbody>
<tr>
<td>SIMOA HD-X</td>
<td>Quanterix</td>
<td>0.038 pg/mL</td>
<td>Research gold standard</td>
</tr>
<tr>
<td>Ella</td>
<td>ProteinSimple</td>
<td>0.1 pg/mL</td>
<td>Microfluidic</td>
</tr>
<tr>
<td>Lumipulse</td>
<td>Fujirebio</td>
<td>1 pg/mL</td>
<td>Automated</td>
</tr>
<tr>
<td>Atellica</td>
<td>Siemens</td>
<td>1.22 pg/mL</td>
<td>FDA cleared (2024)</td>
</tr>
</tbody>
</table>
<h3>Correlation with CSF</h3>
<ul>
<li>r = 0.85-0.91 across studies</li>
<li>Blood levels ~40x lower than CSF</li>
<li>Similar clinical associations</li>
</ul>
<h2>FDA Clearance (2024)</h2>
<h3>Siemens Atellica IM NfL Assay</h3>
<ul>
<li>First FDA-cleared blood NfL test</li>
<li>Indicated as aid in evaluating neurological diseases</li>
<li>Fully automated, high throughput</li>
<li>Enables clinical implementation</li>
</ul>
<h2>Reference Ranges</h2>
<h3>Age-Dependent Normal Values</h3>
<table>
<thead>
<tr>
<th>Age (years)</th>
<th>50th Percentile (pg/mL)</th>
<th>95th Percentile</th>
</tr>
</thead>
<tbody>
<tr>
<td>20-40</td>
<td>7-10</td>
<td>15-20</td>
</tr>
<tr>
<td>40-60</td>
<td>10-15</td>
<td>20-25</td>
</tr>
<tr>
<td>60-80</td>
<td>15-22</td>
<td>25-40</td>
</tr>
<tr>
<td>&gt;80</td>
<td>20-30</td>
<td>35-60</td>
</tr>
</tbody>
</table>
<p><em>Values are approximate and platform-dependent</em></p>
<h2>Clinical Applications by Disease</h2>
<h3>Amyotrophic Lateral Sclerosis</h3>
<ul>
<li><strong>Strongly elevated</strong> (often &gt;100 pg/mL)</li>
<li>Distinguishes from mimics</li>
<li>Prognostic (higher = faster progression)</li>
<li>FDA-cleared indication</li>
</ul>
<h3>Multiple Sclerosis</h3>
<ul>
<li>Elevated during relapses</li>
<li>Tracks disease activity</li>
<li>Predicts disability progression</li>
<li>Treatment response marker</li>
</ul>
<h3>Alzheimer's Disease</h3>
<ul>
<li>Moderately elevated</li>
<li>Correlates with rate of decline</li>
<li>Adds to tau and amyloid markers</li>
<li>Predicts progression in MCI</li>
</ul>
<h3>Frontotemporal Dementia</h3>
<ul>
<li>Strongly elevated</li>
<li>Correlates with survival</li>
<li>Tracks progression</li>
</ul>
<h3>Parkinson's Disease</h3>
<ul>
<li>Mildly elevated</li>
<li>May predict faster progression</li>
<li>Less pronounced than ALS/FTD</li>
</ul>
<h3>Huntington's Disease</h3>
<ul>
<li>Elevated even in premanifest carriers</li>
<li>Tracks with clinical progression</li>
<li>Potential trial outcome measure</li>
</ul>
<!-- NEO4J_CONTENT_START -->
<h2>Relationships</h2>
<h3>Related</h3>
<ul>
<li>→ <a href="/garden/dev_admin/biomarker/neuron-derived-exosome-biomarkers/" class="internal-link">Neuron-Derived_Exosome_Biomarkers</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:15.000097'
source: obsidian
</code></pre>
<ul>
<li>→ <a class="internal-link is-unresolved" href="/404">Traumatic_Brain_Injury</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:15.000097'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/condition/frontotemporal-dementia/" class="internal-link">Frontotemporal_Dementia</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:15.000097'
source: obsidian
</code></pre>
<ul>
<li>→ <a class="internal-link is-unresolved" href="/404">Parkinsons_Disease</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:15.000097'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/biomarker/neurofilament-light-chain/" class="internal-link">Neurofilament_Light_Chain</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:15.000097'
source: obsidian
</code></pre>
<ul>
<li>→ <a class="internal-link is-unresolved" href="/404">Multiple_Sclerosis</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:15.000097'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/biomarker/plasma-p-tau217/" class="internal-link">Plasma_p-tau217</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:15.000097'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/condition/amyotrophic-lateral-sclerosis/" class="internal-link">Amyotrophic_Lateral_Sclerosis</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:15.000097'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/examination/retinal-imaging-for-neurodegeneration/" class="internal-link">Retinal_Imaging_for_Neurodegeneration</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:15.000097'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/examination/alpha-synuclein-saa/" class="internal-link">Alpha-Synuclein_SAA</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:15.000097'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/pathway/tau-phosphorylation/" class="internal-link">Tau_Phosphorylation</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:15.000097'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/biomarker/digital-biomarkers-for-neurodegeneration/" class="internal-link">Digital_Biomarkers_for_Neurodegeneration</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:15.000097'
source: obsidian
</code></pre>
<ul>
<li>→ <a class="internal-link is-unresolved" href="/404">Alzheimers_Disease</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:15.000097'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/pathway/alpha-synuclein-aggregation/" class="internal-link">Alpha-Synuclein_Aggregation</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:15.000097'
source: obsidian
</code></pre>
<ul>
<li>→ <a class="internal-link is-unresolved" href="/404">Huntingtons_Disease</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:15.000097'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/biomarker/blood-nfl/" class="internal-link">Blood_NfL</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:15.000097'
source: obsidian
</code></pre>
<ul>
<li>→ <a class="internal-link is-unresolved" href="/404">Multiple_Sclerosis</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:10.597897'
source: obsidian
</code></pre>
<ul>
<li>→ <a class="internal-link is-unresolved" href="/404">Traumatic_Brain_Injury</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:10.597897'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/biomarker/blood-nfl/" class="internal-link">Blood_NfL</a> (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:03:03.343013'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/pathway/alpha-synuclein-aggregation/" class="internal-link">Alpha-Synuclein_Aggregation</a> (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:10.597897'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/pathway/neuroinflammation/" class="internal-link">Neuroinflammation</a> (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:10.597897'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/pathway/tau-phosphorylation/" class="internal-link">Tau_Phosphorylation</a> (pathway)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:10.597897'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/condition/frontotemporal-dementia/" class="internal-link">Frontotemporal_Dementia</a> (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:10.597897'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/condition/alzheimers-disease/" class="internal-link">Alzheimers_Disease</a> (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:10.597897'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/biomarker/plasma-p-tau217/" class="internal-link">Plasma_p-tau217</a> (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:10.597897'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/condition/amyotrophic-lateral-sclerosis/" class="internal-link">Amyotrophic_Lateral_Sclerosis</a> (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:10.597897'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/biomarker/gfap/" class="internal-link">GFAP</a> (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:10.597897'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/biomarker/neurofilament-light-chain/" class="internal-link">Neurofilament_Light_Chain</a> (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:10.597897'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/condition/parkinsons-disease/" class="internal-link">Parkinsons_Disease</a> (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:10.597897'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/biomarker/uch-l1/" class="internal-link">UCH-L1</a> (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:10.597897'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/condition/huntingtons-disease/" class="internal-link">Huntingtons_Disease</a> (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:10.597897'
source: obsidian
</code></pre>
<ul>
<li>← <a href="/garden/dev_admin/examination/retinal-imaging-for-neurodegeneration/" class="internal-link">Retinal_Imaging_for_Neurodegeneration</a> (examination)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:45.549973'
source: obsidian
</code></pre>
<ul>
<li>← <a href="/garden/dev_admin/examination/alpha-synuclein-saa/" class="internal-link">Alpha-Synuclein_SAA</a> (examination)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:44.082636'
source: obsidian
</code></pre>
<ul>
<li>← <a href="/garden/dev_admin/biomarker/neuron-derived-exosome-biomarkers/" class="internal-link">Neuron-Derived_Exosome_Biomarkers</a> (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:15.353378'
source: obsidian
</code></pre>
<ul>
<li>← <a href="/garden/dev_admin/biomarker/digital-biomarkers-for-neurodegeneration/" class="internal-link">Digital_Biomarkers_for_Neurodegeneration</a> (biomarker)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T07:07:11.464163'
source: obsidian
</code></pre>
<!-- NEO4J_CONTENT_END -->
<h2>Relationships</h2>
<h3>Conditions</h3>
<ul>
<li>→ <a href="/garden/dev_admin/condition/amyotrophic-lateral-sclerosis/" class="internal-link">Amyotrophic Lateral Sclerosis</a> (condition) - <em>Strongly elevated, prognostic</em></li>
<li>→ <a href="/garden/dev_admin/condition/multiple-sclerosis/" class="internal-link">Multiple Sclerosis</a> (condition) - <em>Disease activity marker</em></li>
<li>→ <a href="/garden/dev_admin/condition/alzheimers-disease/" class="internal-link">Alzheimer's Disease</a> (condition) - <em>Moderately elevated</em></li>
<li>→ <a href="/garden/dev_admin/condition/frontotemporal-dementia/" class="internal-link">Frontotemporal Dementia</a> (condition) - <em>Strongly elevated</em></li>
<li>→ <a href="/garden/dev_admin/condition/parkinsons-disease/" class="internal-link">Parkinson's Disease</a> (condition) - <em>Mildly elevated</em></li>
<li>→ <a href="/garden/dev_admin/condition/huntingtons-disease/" class="internal-link">Huntington's Disease</a> (condition) - <em>Premanifest elevation</em></li>
<li>→ <a href="/garden/dev_admin/condition/traumatic-brain-injury/" class="internal-link">Traumatic Brain Injury</a> (condition) - <em>Acute marker</em></li>
</ul>
<h3>Related Biomarkers</h3>
<ul>
<li>→ <a href="/garden/dev_admin/biomarker/neurofilament-light-chain/" class="internal-link">Neurofilament Light Chain</a> (biomarker) - <em>CSF counterpart</em></li>
<li>→ <a href="/garden/dev_admin/biomarker/plasma-p-tau217/" class="internal-link">Plasma p-tau217</a> (biomarker) - <em>AD-specific complement</em></li>
<li>→ <a href="/garden/dev_admin/biomarker/gfap/" class="internal-link">GFAP</a> (biomarker) - <em>Astrocyte marker</em></li>
<li>→ <a href="/garden/dev_admin/biomarker/uch-l1/" class="internal-link">UCH-L1</a> (biomarker) - <em>Neuronal marker</em></li>
</ul>
<h3>Pathways</h3>
<ul>
<li>→ <a href="/garden/dev_admin/pathway/neuroinflammation/" class="internal-link">Neuroinflammation</a> (pathway) - <em>Reflects damage</em></li>
<li>→ <a href="/garden/dev_admin/pathway/alpha-synuclein-aggregation/" class="internal-link">Alpha-Synuclein Aggregation</a> (pathway) - <em>PD marker</em></li>
<li>→ <a href="/garden/dev_admin/pathway/tau-phosphorylation/" class="internal-link">Tau Phosphorylation</a> (pathway) - <em>AD correlate</em></li>
</ul>
<h2>Clinical Utility Summary</h2>
<h3>Strengths</h3>
<table>
<thead>
<tr>
<th>Application</th>
<th>Utility</th>
</tr>
</thead>
<tbody>
<tr>
<td>ALS diagnosis</td>
<td>High (distinguish mimics)</td>
</tr>
<tr>
<td>ALS prognosis</td>
<td>High (predicts survival)</td>
</tr>
<tr>
<td>MS activity</td>
<td>High (treatment monitoring)</td>
</tr>
<tr>
<td>AD staging</td>
<td>Moderate (progression)</td>
</tr>
<tr>
<td>FTD prognosis</td>
<td>High</td>
</tr>
<tr>
<td>General neurodegeneration</td>
<td>High (non-specific)</td>
</tr>
</tbody>
</table>
<h3>Limitations</h3>
<ul>
<li>Non-specific (any cause of axonal damage)</li>
<li>Age-dependent (need adjusted norms)</li>
<li>Acute injury causes spikes</li>
<li>Not disease-specific</li>
<li>Renal impairment elevates levels</li>
</ul>
<h2>Serial Monitoring</h2>
<h3>Change Interpretation</h3>
<ul>
<li>
<blockquote>
<p>20% change considered significant</p>
</blockquote>
</li>
<li>Intra-individual variation ~10-15%</li>
<li>Useful for longitudinal tracking</li>
<li>Treatment response assessment</li>
</ul>
<h3>MS Monitoring Example</h3>
<ul>
<li>Baseline before treatment</li>
<li>Decrease with effective DMT</li>
<li>Stable or rising = consider treatment change</li>
</ul>
<h2>Advantages and Limitations</h2>
<h3>Advantages</h3>
<ul>
<li>FDA-cleared (2024)</li>
<li>Blood draw (accessible)</li>
<li>Pan-neurodegeneration marker</li>
<li>Strong prognostic value</li>
<li>Tracks treatment response (MS)</li>
</ul>
<h3>Limitations</h3>
<ul>
<li>Non-specific for disease</li>
<li>Age adjustment required</li>
<li>Confounded by peripheral neuropathy, renal disease</li>
<li>Not standalone diagnostic</li>
</ul>
<h2>Sample Considerations</h2>
<h3>Collection</h3>
<ul>
<li>Serum or plasma (platform-specific)</li>
<li>Standard phlebotomy</li>
<li>Stable analyte</li>
</ul>
<h3>Stability</h3>
<ul>
<li>Room temperature: 24-48 hours</li>
<li>-80°C: Years</li>
<li>Minimal freeze-thaw effect</li>
</ul>
<h2>References</h2>
<ol>
<li><strong>Multi-Disease Review</strong>: Gaetani, L., et al. (2019). &quot;NfL as a biomarker in neurological disorders.&quot; <em>The Lancet Neurology</em>.</li>
<li><strong>FDA Clearance</strong>: Siemens Healthineers (2024). &quot;Atellica IM NfL assay FDA clearance.&quot;</li>
<li><strong>MS Application</strong>: Barro, C., et al. (2023). &quot;Serum NfL for monitoring MS.&quot; <em>JAMA Neurology</em>.</li>
<li><strong>Reference Values</strong>: Simrén, J., et al. (2022). &quot;Age-specific reference ranges for serum NfL.&quot; <em>JAMA Neurology</em>.</li>
</ol>

{% endraw %}